STEMI
Clinical trials for STEMI explained in plain language.
Never miss a new study
Get alerted when new STEMI trials appear
Sign up with your email to follow new studies for STEMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart clot showdown: newer blood thinner may be safer and just as effective
Disease control OngoingThis study tests whether a newer type of blood thinner (direct oral anticoagulant) works better than the standard one (vitamin K antagonist) for dissolving blood clots inside the heart. About 340 adults with such clots will be randomly assigned to one of the two treatments. The g…
Matched conditions: STEMI
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
Could a diabetes pill protect heart attack patients during emergency artery repair?
Disease control OngoingThis study tests whether empagliflozin, a diabetes drug, can reduce the risk of 'no-reflow'—a dangerous complication where blood flow isn't fully restored after angioplasty for a heart attack. About 162 adults with ST-elevation heart attacks will receive either the drug or a plac…
Matched conditions: STEMI
Phase: PHASE2 • Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez • Aim: Disease control
Last updated May 26, 2026 04:53 UTC
-
Heart shock study tests escalating support to save lives
Disease control OngoingThis study looks at whether quickly increasing the use of mechanical heart pumps can help people survive a severe heart attack complicated by cardiogenic shock, where the heart can't pump enough blood. Researchers will follow 124 patients at 20 hospitals in the United States to s…
Matched conditions: STEMI
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Experimental antibody aims to limit heart muscle damage after STEMI
Disease control OngoingThis early-stage study tests a monoclonal antibody called atibuclimab (IC14) in 10 adults who had a severe heart attack (STEMI) and received a stent. The drug is given by IV to see if it can prevent further heart muscle damage and reduce inflammation. Participants are compared to…
Matched conditions: STEMI
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
AI reads your Heart's electrical signals to spot blockages instantly
Diagnosis OngoingThis study uses artificial intelligence to analyze standard ECG readings from 800 people having a heart attack. The AI aims to quickly identify which artery is blocked and how severe the blockage is, helping doctors decide on the best treatment faster. Participants are adults wit…
Matched conditions: STEMI
Sponsor: Powerful Medical • Aim: Diagnosis
Last updated May 22, 2026 13:52 UTC